Consistent with the above results, the proportion of EdU-positive proliferating NPC cells reduced significantly following TRPV4 knockdown or HC0670476 (4 μM) treatment (Figures 3F–H). This evidence concerns the gene TRPV4 and nasopharyngeal carcinoma.